Nextgenjane Inc.
Oakland, CA
- UEI
- EWN3LW7S8NP5
- CAGE
- 7GP46
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- SUMMIT PROFESSIONAL BUILDING, 400 29th St #105, Oakland, CA 94609, USA
- Website
- nextgenjane.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients - summary… | National Institute of Child Health and Human Development | $1,474,039 | |
| Developing a non-invasive, definitive diagnostic for endometriosis using biomarkers in menstrual effluence | National Institute of Child Health and Human Development | $4,396,157 |
About Nextgenjane Inc.
Nextgenjane Inc. is a women's health startup based in Oakland, California, focused on developing innovative diagnostic technologies for reproductive health conditions. Registered in SAM.gov since 2015, the company specializes in non-invasive diagnostic testing, with a particular emphasis on creating advanced screening methods for complex conditions like endometriosis. Their core technological approach involves developing specialized collection systems and genomic assays that can analyze menstrual fluid to detect biomarkers associated with specific reproductive health challenges.
The company has received significant federal grant funding from the National Institute of Child Health and Human Development (NICHD), primarily focused on developing a non-invasive diagnostic test for endometriosis. Their primary federal grant awards, totaling approximately $759,944, support research to create a reliable "yes/no" diagnostic tool that can detect endometriosis using biomarkers in menstrual fluid. Nextgenjane Inc. has also been an active sub-grantee for Baylor College of Medicine, providing critical research support including equipment, training for immune cell isolations, collection kits, and sequencing services for menstrual sample studies. Their research involves complex genomic analysis, including RNA sequencing and statistical classification of biomarkers, with the ultimate goal of improving early detection and understanding of endometriosis. The company's work demonstrates a sophisticated approach to medical research, combining advanced technological methods with a focus on addressing significant unmet medical needs in women's reproductive health.
Quick answers
What is Nextgenjane Inc.'s UEI?
Nextgenjane Inc.'s Unique Entity ID (UEI) in SAM.gov is EWN3LW7S8NP5.
What is Nextgenjane Inc.'s CAGE code?
Nextgenjane Inc.'s CAGE code is 7GP46.
What is Nextgenjane Inc.'s primary NAICS code?
Nextgenjane Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Nextgenjane Inc. located?
Nextgenjane Inc.'s physical address in SAM.gov is SUMMIT PROFESSIONAL BUILDING, 400 29th St #105, Oakland, CA 94609, USA.
Is Nextgenjane Inc. registered in SAM.gov?
Yes. Nextgenjane Inc.'s SAM.gov registration is active through March 12, 2027.
What is Nextgenjane Inc.'s most recent federal award?
Nextgenjane Inc.'s most recent federal grant award is Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients - summary… (R44HD118899), from National Institute of Child Health and Human Development, on April 15, 2025.
On GovTribe
See Nextgenjane Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors